Latest Breaking News On - B future health fund - Page 1 : vimarsana.com

Domain Therapeutics to Present Latest Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology, at AACR 2024 Annual Meeting, Highlighting Clear Competitive Advantages of This Candidate

Domain Therapeutics to Present Latest Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology, at AACR 2024 Annual Meeting, Highlighting Clear Competitive Advantages of This Candidate
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

California
United-states
San-diego
American
America
Stephan-schann
Namrata-taak
Dennis-riedl
Amber-fennell
Schroders
B-future-health-fund
Merck-kga

NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline

NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Luxembourg
Tokyo
Japan
Italy
United-kingdom
Boston
Massachusetts
London
City-of
Italian
Simon-fiduciaria

NeoPhore's small molecule drugs pipeline gets additional £9.6M

A company building a pipeline of small molecule drugs targeting novel proteins across the DNA mismatch repair (pathway) has announced a further extension to its series B financing round.

Boston
Massachusetts
United-states
Italy
Intesa-sanpaolo
Stefano-buono
Matthew-baker
Simon-fiduciaria
Robert-james
B-future-health-fund
Ersel-group
Neophore-limited

NeoPhore Raises Additional £9.6M in Series B Extension Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

London
City-of
United-kingdom
Intesa-sanpaolo
Simon-fiduciaria
Matthew-baker
Stefano-buono
University-of-turin
Phoremost-ltd
Pioneer-fund
B-future-health-fund
United-kingdom-based

Updated clinical safety and efficacy data for iOnctura's roginolisib presented at ESMO Immuno-Oncology Congress 2023

Updated clinical safety and efficacy data for iOnctura's roginolisib presented at ESMO Immuno-Oncology Congress 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Amsterdam
Noord-holland
Netherlands
Switzerland
Geneva
Genè
Swiss
Catherine-pickering
Stefan-klotter
Oncology-congress
B-future-health-fund
Response-evaluation-criteria

On Target Laboratories Secures $30 Million for Commercialization of CYTALUX® (pafolacianine) injection

On Target Laboratories Secures $30 Million for Commercialization of CYTALUX® (pafolacianine) injection
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states
Ralphc-corley
Gwen-watanabe
Ben-lundgren
Prnewswire-on-target-laboratories-inc
Laboratories-inc
Purdue-university-presidential-scholar-for-drug-discovery
Hurvis-group
Centers-for-medicare-medicaid-services
Pension-fund-of-the-christian-church
B-future-health-fund
Target-laboratories-secures

iOnctura to present research on roginolisib and IOA-359 at ASH

iOnctura to present research on roginolisib and IOA-359 at ASH
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland
United-states
California
San-diego-convention-center
Netherlands
Amsterdam
Noord-holland
Geneva
Genè
San-diego
American
Swiss

iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kd

iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kd
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Geneva
Genè
Switzerland
United-states
Amsterdam
Noord-holland
Netherlands
Swiss
America
Catherine-pickering
Drug-administration
B-future-health-fund

iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kδ

iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kδ
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Geneva
Genè
Netherlands
Amsterdam
Noord-holland
United-states
America
Swiss
Catherine-pickering
Drug-administration
B-future-health-fund

New research highlights potential of iOnctura strategy combining autotaxin and TGF-ß inhibitors in cancer

New research highlights potential of iOnctura strategy combining autotaxin and TGF-ß inhibitors in cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Netherlands
Switzerland
Amsterdam
Noord-holland
Geneva
Genè
Swiss
Davide-melisi
Catherine-pickering
Indiens-wirtschaft
Ihre-chancen
University-of-verona